BioStock Investor Meeting: OssDsign presents

Medtech company OssDsign develops and manufactures regenerative implants and patient-specific solutions for the treatment of bone defects. CFO Anders Svensson attended the BioStock Investor Meeting where he talked about how sales in Japan have taken off and the company’s plans for the US market.

See the full presentation at biostock.se:

https://www.biostock.se/en/2022/09/biostock-investor-meeting-ossdsign-presents/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se